ZM-008

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameZM-008
Drug Alias NameZM-008ZM008
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsC-type lectin antagonistsNatural killer cells stimulants +[4] 
TargetsC-type lectinsC-Type Lectin Domain Family 2 Member D
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung +[14] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesZumutor Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesZumutor Biologics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung +[14] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A